Material Safety Data Sheet Section 1. Identification of the substance Product Name: 4-Bromo-3-fluorothioanisole Synonyms: (4-Bromo-3-fluorophenyl)(methyl)sulfane Section 2. Hazards identification Harmful by inhalation, in contact with skin, and if swallowed. Section 3. Composition/information on ingredients. Ingredient name: 4-Bromo-3-fluorothioanisole CAS number: 917562-25-5 Section 4. First aid measures Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing contaminated clothing and shoes. If irritation persists, seek medical attention. Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical attention. Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention. Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention. Section 5. Fire fighting measures In the event of a fire involving this material, alone or in combination with other materials, use dry powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus should be worn. Section 6. Accidental release measures Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national standards. Respiratory precaution: Wear approved mask/respirator Hand precaution: Wear suitable gloves/gauntlets Skin protection: Wear suitable protective clothing Eye protection: Wear suitable eye protection Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container for disposal. See section 12. Environmental precautions: Do not allow material to enter drains or water courses. Section 7. Handling and storage Handling: This product should be handled only by, or under the close supervision of, those properly qualified in the handling and use of potentially hazardous chemicals, who should take into account the fire, health and chemical hazard data given on this sheet. Store in closed vessels. Storage: Section 8. Exposure Controls / Personal protection Engineering Controls: Use only in a chemical fume hood. Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles. General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse. Section 9. Physical and chemical properties Appearance: Not specified Boiling point: No data No data Melting point: Flash point: No data Density: No data Molecular formula: C7H6BrFS Molecular weight: 221.1 Section 10. Stability and reactivity Conditions to avoid: Heat, flames and sparks. Materials to avoid: Oxidizing agents. Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide, sulfur oxides. Section 11. Toxicological information No data. Section 12. Ecological information No data. Section 13. Disposal consideration Arrange disposal as special waste, by licensed disposal company, in consultation with local waste disposal authority, in accordance with national and regional regulations. Section 14. Transportation information Non-harzardous for air and ground transportation. Section 15. Regulatory information No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302, or have known CAS numbers that exceed the threshold reporting levels established by SARA Title III, Section 313.
The present invention relates to novel compounds of formula (I), process for preparation of the same and composition comprising these compounds.
本发明涉及公式(I)的新化合物,其制备方法以及包含这些化合物的组合物。
NOVEL COMPOUNDS AS GPR119 AGONISTS
申请人:Mankind Pharma Ltd.
公开号:US20170291910A1
公开(公告)日:2017-10-12
The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.
本发明涉及式(I)的新化合物作为GPR119激动剂,包含此类化合物的组合物及其制备方法。
BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS
申请人:Fang Jing
公开号:US20100029650A1
公开(公告)日:2010-02-04
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
[EN] ANTIBACTERIAL 2H-INDAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE 2H-INDAZOLE ANTIBACTÉRIENS
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2015036964A1
公开(公告)日:2015-03-19
The invention relates to antibacterial compounds of formula (I) wherein R1 is H or halogen; R2 is alkynyloxy or the group M; R3 is H or halogen; M is one of the groups (A, B, C, D) wherein A is a bond, CH2 CH2, CH=CH or C≡C and R1A, R2A, R3A, R1B and R1C are as defined in claim 1; and salts thereof.
NEW BICYCLIC COMPOUND FOR MODULATING G PROTEIN-COUPLED RECEPTORS
申请人:Son Jung Beom
公开号:US20130274268A1
公开(公告)日:2013-10-17
The present invention relates to a bicyclic compound for modulating G protein-coupled receptors. The inventive compound provides preventing or treating a disease associated with the modulation of G protein-coupled receptors, particularly GPR119 G protein-coupled receptors.